Cancer stem cells and hypoxia-inducible factors (Review).

Int J Oncol

Department of Laboratory Medicine, Shengjing Affiliated Hospital, China Medical University, Shenyang, Liaoning 110004, P.R. China.

Published: August 2018

Cancer stem cells (CSCs), also known as tumor-initiating cells, are a subpopulation of tumor cells that exhibit properties similar to those of normal stem cells. Oxygen is an important regulator of cellular metabolism; hypoxia-inducible factors (HIFs) mediate metabolic switches in cells in hypoxic environments. Hypoxia clearly has the potential to exert a significant effect on the maintenance and evolution of CSCs. Both HIF‑1α and HIF‑2α may contribute to the regulation of cellular adaptation to hypoxia and resistance to cancer therapies. This review provides an overview of the roles of HIFs in CSCs. HIF‑1α and HIF‑2α have significant prognostic and predictive value in the clinic and the concept of personalized medicine should be applied in designing clinical trials for HIF inhibitors.

Download full-text PDF

Source
http://dx.doi.org/10.3892/ijo.2018.4417DOI Listing

Publication Analysis

Top Keywords

stem cells
12
cancer stem
8
cscs hif‑1α
8
hif‑1α hif‑2α
8
cells
6
cells hypoxia-inducible
4
hypoxia-inducible factors
4
factors review
4
review cancer
4
cells cscs
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!